Herantis Pharma Valuation
| HRTIS Stock | EUR 1.49 0.07 4.49% |
Based on Macroaxis valuation methodology, the firm appears to be overvalued. Herantis Pharma Oyj retains a regular Real Value of €1.26 per share. The prevalent price of the firm is €1.49. Our model calculates the value of Herantis Pharma Oyj from evaluating the firm fundamentals such as Return On Equity of -13.37, return on asset of -0.6, and Shares Owned By Insiders of 31.52 % as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Herantis Pharma's price fluctuation is very risky at this time. Calculation of the real value of Herantis Pharma Oyj is based on 3 months time horizon. Increasing Herantis Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Herantis Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Herantis Stock. However, Herantis Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.49 | Real 1.26 | Hype 1.56 |
The intrinsic value of Herantis Pharma's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Herantis Pharma's stock price.
Estimating the potential upside or downside of Herantis Pharma Oyj helps investors to forecast how Herantis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Herantis Pharma more accurately as focusing exclusively on Herantis Pharma's fundamentals will not take into account other important factors: Herantis Pharma Total Value Analysis
Herantis Pharma Oyj is currently forecasted to have takeover price of 25.86 M with market capitalization of 39.58 M, debt of 6.29 M, and cash on hands of 7.86 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Herantis Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
25.86 M | 39.58 M | 6.29 M | 7.86 M |
Herantis Pharma Asset Utilization
One of the ways to look at asset utilization of Herantis is to check how much profit was generated for every dollar of assets it reports. Herantis Pharma retains a negative application of resources of -0.6 (percent), losing €0.006005 for each euro of resources held by the firm. Inadequate asset utilization attests that the company is being less effective with each euro of resources it retains. Simply put, asset utilization of Herantis Pharma Oyj shows how discouraging it operates for each euro spent on its resources.Herantis Pharma Ownership Allocation
Herantis Pharma Oyj has a total of 16.91 Million outstanding shares. Herantis Pharma secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Herantis Pharma Profitability Analysis
Net Loss for the year was (12.77 M) with profit before overhead, payroll, taxes, and interest of 90 K.About Herantis Pharma Valuation
An absolute valuation paradigm, as applied to Herantis Stock, attempts to find the value of Herantis Pharma Oyj based on its fundamental and basic technical indicators. By analyzing Herantis Pharma's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Herantis Pharma's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Herantis Pharma. We calculate exposure to Herantis Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Herantis Pharma's related companies.Herantis Pharma Oyj, a drug development company, focuses on developing regenerative therapeutics. The company was founded in 2008 and is based in Espoo, Finland. Herantis Pharma operates under Pharmaceuticals And Biosciences classification in Finland and is traded on Helsinki Exchange. It employs 13 people.
8 Steps to conduct Herantis Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Herantis Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Herantis Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Herantis Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Herantis Pharma's revenue streams: Identify Herantis Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Herantis Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Herantis Pharma's growth potential: Evaluate Herantis Pharma's management, business model, and growth potential.
- Determine Herantis Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Herantis Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for Herantis Stock analysis
When running Herantis Pharma's price analysis, check to measure Herantis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Herantis Pharma is operating at the current time. Most of Herantis Pharma's value examination focuses on studying past and present price action to predict the probability of Herantis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Herantis Pharma's price. Additionally, you may evaluate how the addition of Herantis Pharma to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |